You are here

Drug Discovery & Development Related Content


David Yue-Wei Lee, PhD

Dr. Lee has worked on numerous drug discovery projects related to traditional Chinese medicine, contributing significantly to the development of alternative therapies for substance abuse and for osteoarthritis. He is the principal investigator on “Alternative Therapies for Alcohol and Drug...

Scott E. Lukas, PhD

Scott E. Lukas received his PhD in pharmacology and toxicology in 1979 from the University of Maryland. After a post-doctoral fellowship at Johns Hopkins University, he joined NIDA Addiction Research Center for 18 months before moving to McLean in 1984. Promoted to professor in 2003, Dr. Lukas...

John L. Neumeyer, PhD

John L. Neumeyer, PhD, received his BS from Columbia University, and PhD in medicinal chemistry from the University of Wisconsin, Madison. He became a professor of medicinal chemistry and chemistry at Northeastern University in 1969, was appointed Matthews Distinguished Professor in1980, and was a...

Peter Siekmeier, MS, MD

As director of the Laboratory for Computational Neuroscience, Dr. Siekmeier’s research centers on the computational modeling of the hippocampus, an area of brain thought to be responsible for encoding memories, and one that has been implicated in the etiology of schizophrenia. The goals of...

Frank I. Tarazi, MBBS, PhD, MBA

Frank I. Tarazi, MBBS, PhD, MBA, is an associate professor of psychiatry at Harvard Medical School and director of the Psychiatric Neuroscience Laboratory at McLean Hospital. His research focuses on better understanding the pathophysiology of neuropsychiatric disorders and their improved treatment....